InMode (INMDN) Stock Price & Analysis
INMDN Stock Chart & Stats
- Day’s Range
- MXN 251.20 - MXN 251.20
- 52-Week Range
- MXN 240.00 - MXN 261.86
- Previous Close
- MXN 251.20
- Volume
- 0
- Average Volume (3M)
- 184
- Market Cap
- MXN 14.30B
- Enterprise Value
- MXN 371.44M
- Total Cash (Recent Filing)
- MXN 501.12M
- Total Debt (Recent Filing)
- MXN 4.45M
- Price to Earnings (P/E)
- 10.6
- Beta
- 0.05
- Next Earnings
- Nov 11, 2026 (Est.)
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Very Low Leverage
An exceptionally conservative capital structure gives InMode resilience if demand weakens and preserves capacity to fund product development, commercial investment, or shareholder returns. Minimal debt also limits refinancing exposure and interest burdens, supporting durable financial flexibility over the coming quarters.
Strong Cash Conversion
Operating results are translating effectively into cash, indicating that reported earnings are supported by underlying business generation rather than weak-quality accruals. This conversion provides internally generated resources for investment, operations, and capital allocation despite slower growth.
Recurring Revenue Expansion
Growth in consumables and service revenue strengthens the economics of InMode’s installed equipment base by adding repeat-purchase streams beyond one-time system sales. Continued expansion in these categories can improve revenue durability and reduce reliance on periodic capital-equipment upgrades.
Bears Say
Weak Revenue Trajectory
A flat revenue base following two years of declines indicates that demand and commercial momentum have cooled from earlier periods. Sustained stagnation could constrain operating leverage, limit reinvestment capacity, and make future earnings growth more dependent on cost control.
Margin Compression
Higher operating costs and restructuring have reduced profitability even though revenue remained stable, demonstrating weaker near-term operating leverage. If elevated expenses persist through new platform rollouts and commercial changes, earnings recovery may lag any improvement in sales.
Strategic Process Uncertainty
An unresolved strategic review can distract management and create uncertainty around capital allocation, governance, and the company’s long-term direction. The absence of an NDA with potential parties also indicates that a transaction or other strategic outcome remains unsettled.
InMode News
INMDN FAQ
What was InMode’s price range in the past 12 months?
What is InMode’s market cap?
When is InMode’s upcoming earnings report date?
How were InMode’s earnings last quarter?
Is InMode overvalued?
Does InMode pay dividends?
What is InMode’s EPS estimate?
How many shares outstanding does InMode have?
What happened to InMode’s price movement after its last earnings report?
Which hedge fund is a major shareholder of InMode?
What is the TipRanks Smart Score and how is it calculated?
InMode Stock Smart Score
Company Description
InMode
InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies. These advanced devices facilitate a range of procedures, such as liposuction with concurrent skin firming, body and facial sculpting, intensive skin resurfacing treatments, and various women's health-related aesthetic interventions. Beyond these, InMode also provides non-invasive medical aesthetic products designed to address numerous cosmetic concerns. These include lasting hair removal, facial skin revitalization, the reduction of wrinkles, cellulite improvement, enhancing overall dermal quality and texture, and treating minor vascular and pigmented skin imperfections. Furthermore, the company develops automated, hands-free medical aesthetic systems for applications like dermal tightening, adipose tissue reduction, and muscular toning. Established in 2008, InMode Ltd. operates from its headquarters in Yokneam, Israel. The company was previously known as Invasix Ltd. before officially changing its name in November 2017.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Moshe Mizrahy
- Employees
- 660
- Website
- www.inmodemd.com
- Address
- Tavor Building, Yokne'am, TA, 2069206, IL
InMode (INMDN) Earnings & Revenues
INMDN Earnings Call
Earnings Call SentimentNeutral
The call contained a mix of modest top-line progress and strategic positives (5% revenue growth, strong cash balance, product launches, sales reorganization and share repurchases) offset by notable margin compression, rising operating expenses and declines in EPS. Management provided steady full-year guidance and described early signs of stabilization in the U.S., but profitability pressures and macroeconomic headwinds temper the outlook. International and product development initiatives offer upside, while near-term margin and demand uncertainty are the primary negatives.
View all MX:INMDN earnings summariesINMDN Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 13 | 1 | 3 |
| Technical Analysis | 4 | 1 | 2 |
| Moving Averages | 9 | 0 | 1 |
